178 related articles for article (PubMed ID: 16964284)
1. Prohibitin, a protein downregulated by androgens, represses androgen receptor activity.
Gamble SC; Chotai D; Odontiadis M; Dart DA; Brooke GN; Powell SM; Reebye V; Varela-Carver A; Kawano Y; Waxman J; Bevan CL
Oncogene; 2007 Mar; 26(12):1757-68. PubMed ID: 16964284
[TBL] [Abstract][Full Text] [Related]
2. Reducing prohibitin increases histone acetylation, and promotes androgen independence in prostate tumours by increasing androgen receptor activation by adrenal androgens.
Dart DA; Brooke GN; Sita-Lumsden A; Waxman J; Bevan CL
Oncogene; 2012 Oct; 31(43):4588-98. PubMed ID: 22179832
[TBL] [Abstract][Full Text] [Related]
3. Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours.
Dart DA; Spencer-Dene B; Gamble SC; Waxman J; Bevan CL
Endocr Relat Cancer; 2009 Dec; 16(4):1157-69. PubMed ID: 19635783
[TBL] [Abstract][Full Text] [Related]
4. Prohibitin and the SWI/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genes.
Dai Y; Ngo D; Jacob J; Forman LW; Faller DV
Carcinogenesis; 2008 Sep; 29(9):1725-33. PubMed ID: 18487222
[TBL] [Abstract][Full Text] [Related]
5. A repressive role for prohibitin in estrogen signaling.
He B; Feng Q; Mukherjee A; Lonard DM; DeMayo FJ; Katzenellenbogen BS; Lydon JP; O'Malley BW
Mol Endocrinol; 2008 Feb; 22(2):344-60. PubMed ID: 17932104
[TBL] [Abstract][Full Text] [Related]
6. Prohibitin Links Cell Cycle, Motility and Invasion in Prostate Cancer Cells.
Koushyar S; Uysal-Onganer P; Jiang WG; Dart DA
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373067
[TBL] [Abstract][Full Text] [Related]
7. The prohibitin-repressive interaction with E2F1 is rapidly inhibited by androgen signalling in prostate cancer cells.
Koushyar S; Economides G; Zaat S; Jiang W; Bevan CL; Dart DA
Oncogenesis; 2017 May; 6(5):e333. PubMed ID: 28504694
[TBL] [Abstract][Full Text] [Related]
8. Sirtuin 1 is required for antagonist-induced transcriptional repression of androgen-responsive genes by the androgen receptor.
Dai Y; Ngo D; Forman LW; Qin DC; Jacob J; Faller DV
Mol Endocrinol; 2007 Aug; 21(8):1807-21. PubMed ID: 17505061
[TBL] [Abstract][Full Text] [Related]
9. Modulation of androgen receptor transactivation by FoxH1. A newly identified androgen receptor corepressor.
Chen G; Nomura M; Morinaga H; Matsubara E; Okabe T; Goto K; Yanase T; Zheng H; Lu J; Nawata H
J Biol Chem; 2005 Oct; 280(43):36355-63. PubMed ID: 16120611
[TBL] [Abstract][Full Text] [Related]
10. Sterol regulatory element-binding protein-1c represses the transactivation of androgen receptor and androgen-dependent growth of prostatic cells.
Suh JH; Gong EY; Kim JB; Lee IK; Choi HS; Lee K
Mol Cancer Res; 2008 Feb; 6(2):314-24. PubMed ID: 18245227
[TBL] [Abstract][Full Text] [Related]
11. CR6-interacting factor 1 represses the transactivation of androgen receptor by direct interaction.
Suh JH; Shong M; Choi HS; Lee K
Mol Endocrinol; 2008 Jan; 22(1):33-46. PubMed ID: 17885209
[TBL] [Abstract][Full Text] [Related]
12. Regulation of a novel androgen receptor target gene, the cyclin B1 gene, through androgen-dependent E2F family member switching.
Li Y; Zhang DY; Ren Q; Ye F; Zhao X; Daniels G; Wu X; Dynlacht B; Lee P
Mol Cell Biol; 2012 Jul; 32(13):2454-66. PubMed ID: 22508987
[TBL] [Abstract][Full Text] [Related]
13. Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer.
Fletcher CE; Dart DA; Sita-Lumsden A; Cheng H; Rennie PS; Bevan CL
Hum Mol Genet; 2012 Jul; 21(14):3112-27. PubMed ID: 22505583
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor corepressor-19 kDa (ARR19), a leucine-rich protein that represses the transcriptional activity of androgen receptor through recruitment of histone deacetylase.
Jeong BC; Hong CY; Chattopadhyay S; Park JH; Gong EY; Kim HJ; Chun SY; Lee K
Mol Endocrinol; 2004 Jan; 18(1):13-25. PubMed ID: 14576337
[TBL] [Abstract][Full Text] [Related]
15. Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation.
Gaughan L; Logan IR; Neal DE; Robson CN
Nucleic Acids Res; 2005; 33(1):13-26. PubMed ID: 15640443
[TBL] [Abstract][Full Text] [Related]
16. Targeted disruption of the p160 coactivator interface of androgen receptor (AR) selectively inhibits AR activity in both androgen-dependent and castration-resistant AR-expressing prostate cancer cells.
Nakka M; Agoulnik IU; Weigel NL
Int J Biochem Cell Biol; 2013 Apr; 45(4):763-72. PubMed ID: 23270728
[TBL] [Abstract][Full Text] [Related]
17. Corepressor effect on androgen receptor activity varies with the length of the CAG encoded polyglutamine repeat and is dependent on receptor/corepressor ratio in prostate cancer cells.
Buchanan G; Need EF; Barrett JM; Bianco-Miotto T; Thompson VC; Butler LM; Marshall VR; Tilley WD; Coetzee GA
Mol Cell Endocrinol; 2011 Aug; 342(1-2):20-31. PubMed ID: 21664238
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for nuclear receptor corepressor recruitment by antagonist-liganded androgen receptor.
Hodgson MC; Shen HC; Hollenberg AN; Balk SP
Mol Cancer Ther; 2008 Oct; 7(10):3187-94. PubMed ID: 18852122
[TBL] [Abstract][Full Text] [Related]
19. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
Yoon HG; Wong J
Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate.
Powell SM; Christiaens V; Voulgaraki D; Waxman J; Claessens F; Bevan CL
Endocr Relat Cancer; 2004 Mar; 11(1):117-30. PubMed ID: 15027889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
